All news articles for February 2023

VIDEO: Postbiotic scientific discoveries boost consumer awareness

Insights from Probiota 2023

VIDEO: Postbiotic scientific discoveries boost consumer awareness

By Nikki Hancocks

Postbiotics are increasingly seen as an ideal focus for innovators in the world of microbiome modulation but hurdles are created by the lack of use of the word, by both consumers and the industry itself, according to industry experts at Probiota.

Health drinks startup provides personalised nutrition to pro-athletes

Startup Spotlight

Health drinks startup provides personalised nutrition to pro-athletes

By Olivia Haslam

Three-year-young cold-pressed health drink startup, Exalt, is set to provide bespoke recovery drinks to the premier league football club Tottenham Hotspur, with regular nutrition reformulations based on athletes' health stats and targets.

Don’t call it a comeback, chia’s been here for years

Don’t call it a comeback, chia’s been here for years

By Asia Sherman

Chia became a household name in the 1980s, popularized by the fascination with fur-sprouting animal figurines, but its use as health aid dates as far back as the Aztec and Mayan empires. Today, after a slight dip in the market, chia is back on the scene...

© nadisja / Getty Images

Study highlights rapid benefits from DE111 probiotic

By Stephen Daniells

Acute supplementation with ADM’s Bacillus subtilis DE111 probiotic leads to detectable changes on the microbiome within hours, says a new study that supports the efficacy of the strain.

Study champions CBD with THC for insomnia

Study champions CBD with THC for insomnia

By Olivia Haslam

A broad-spectrum medicinal cannabis oil is effective in significantly improving sleep quality and duration, midnight melatonin levels, as well as quality of life and mood within two weeks, in adults with insomnia, according to new research.

Study: CBD may lower blood pressure in hypertensive patients

Study: CBD may lower blood pressure in hypertensive patients

By Olivia Brown

After five-weeks of CBD administration to hypertensive patients, reductions in blood pressure were paired with significant drops in the catestatin peptides involved in hypertension pathophysiology, a randomised controlled trial observes.

Follow us

Products

View more

Webinars